Fresenius | FRE

Fresenius traded at 24.15 this Wednesday March 29th, increasing 0.21 or 0.88 percent since the previous trading session. Looking back, over the last four weeks, Fresenius gained 3.75 percent. Over the last 12 months, its price fell by 26.15 percent. Looking ahead, we forecast Fresenius to be priced at 22.84 by the end of this quarter and at 20.67 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
24.41
Daily Change
1.08%
Yearly
-26.80%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Akzo Nobel 68.58 0.98 1.45% -13.17%
Alcon AG 62.02 -0.68 -1.08% -17.48%
AstraZeneca 11,166.00 32.00 0.29% 9.90%
BASF 48.03 0.85 1.80% -9.87%
Bayer 57.56 0.29 0.51% -6.97%
Beiersdorf 118.10 0 0% 23.02%
DSM 109.65 -0.15 -0.14% -32.65%
DaVita Healthcare Partners 78.47 1.12 1.45% -31.55%
Essilor 162.45 2.20 1.37% -4.93%
E.ON 11.50 0.12 1.01% 7.63%
Fresenius Medical Care 38.58 0.44 1.15% -35.70%
Fresenius Medical Care 20.64 -0.02 -0.10% -38.52%
Fresenius 24.41 0.26 1.08% -26.80%
Getinge 248.30 0.90 0.36% -35.24%
Givaudan 2,971.00 15.00 0.51% -22.37%
GN Store Nord 153.30 2.60 1.73% -53.92%
GRIFOLS 9.02 0.13 1.46% -45.33%
GlaxoSmithKline 1,416.00 -4.60 -0.32% -14.74%
Hikma Pharmaceutical 1,654.50 9.50 0.58% -20.00%
Lonza Group 540.60 4.60 0.86% -19.31%
Merck 171.15 1.95 1.15% -9.85%
Novartis 82.93 -0.54 -0.65% 1.57%
Philips 16.15 0.62 3.98% -42.59%
Roche Holding 260.90 2.05 0.79% -29.64%
RWE 38.97 0.25 0.65% -1.42%
Sanofi 100.52 -0.48 -0.48% 8.66%
Smith & Nephew PLC 1,105.50 -15.00 -1.34% -10.74%
William Demant Holding 242.80 2.80 1.17% -19.84%

Indexes Price Day Year
DE40 15501 172.12 1.12% 7.54%
EU50 4271 39.93 0.94% 9.45%

Fresenius
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.